Finnrick, an independent testing programme, publishes 20 assays for Kerisite Shenzhen International: 11 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 9 did not. Most recent assay 15 May 2026.
Kerisite Shenzhen International operates from China, listed by Finnrick as "Not found". Source: Finnrick, https://www.finnrick.com/vendors/kerisite-shenzhen-international.
Finnrick-tested with mixed results. Tested across 2 peptide products with 19 total samples.
Kerisite Shenzhen International is listed as active. Finnrick Grade C. Finnrick avg score: 7.3/10 across 19 samples (2 products). Mixed quality — some products test well, others below average.
Kerisite Shenzhen International holds independent lab grade C, assigned across 19 graded samples, average score 7.3/10. That grade comes from an independent grader's own sampling, not from PeptideAtlas, and it describes the samples that grader obtained rather than every batch sold.
No independent third-party assay is on file for Kerisite Shenzhen International, and we have not yet compiled a profile of its own website. An untested vendor has not failed a test — this is an absence of evidence, not evidence against it.
| Product | Assays | Result |
|---|---|---|
| Retatrutide | 18 | 11 passed, 7 failed |
| Cagrilintide | 2 | 0 passed, 2 failed |
Source: Finnrick, as published 2026-08-09. Pass and fail are Finnrick's classification against its own threshold, not ours.
| Status | Active |
|---|---|
| Independent lab grade | C (19 samples) |
| Average grader score | 7.3/10 |
| Vendor type | Research-use supplier |
Kerisite Shenzhen International is listed as active and we hold 20 Finnrick assays (11 passing, 9 failing its purity threshold); an independent lab grade of C. That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.
Yes. Finnrick, an independent testing programme, publishes 20 assays for Kerisite Shenzhen International: 11 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 9 did not. Most recent assay 15 May 2026.
Similar vendors: Peptide Sciences, Limitless Life Nootropics, Polaris Peptides, NextechLabs, Yiwu Aozuo Trading Co, Shandong Shengyuan Peptide Technology, Bulk Peptide Supply, Skye Peptides.
Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.
Other reviewed vendors: Kerui Peptide HongKong Review, Kismet Technologies Peptides Review, Kits4less Peptides Review.